16 September 2026 editorial review · Item
Beta Bionics iLet Bionic Pancreas: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: Beta Bionics iLet Bionic Pancreas
Scope and findings:
- Added conditional Q4 Eversense 365–iLet partnership milestone; no current shipping/approved pairing claim.
- Added conditional 3D Intelligence submission; distinguished current iLet from uncleared next-generation algorithm.
Primary sources checked:
Limits: The review is restricted to the scopes above. Historical efficacy estimates, editorial scoring and country-specific access were not fully reverified unless expressly stated. A manufacturer or conference report retains that evidence level.